Navigation Links
Study: Majority of epilepsy surgery patients enjoy improvement in their physical and social well-being
Date:12/8/2013

DETROIT The majority of epilepsy patients who have brain surgery to treat their disorder are satisfied with the results in reducing epilepsy-related seizures and improving their psychological and social well-being.

Those were the conclusions of a new study by Henry Ford Hospital researchers who examined the medical records of epilepsy surgery patients and conducted a telephone survey to determine their satisfaction with the results of the procedure.

"Overall, the great majority of patients, 92 percent of them, expressed satisfaction with undergoing epilepsy surgery," says Vibhangini S. Wasade, M.D., a Henry Ford Hospital neurologist and lead author of the study.

"Following surgery, more patients were able to drive, and those with favorable seizure outcomes were more likely to be employed full-time and less likely to be taking antidepressant medication," Dr. Wasade adds.

The research will be presented at the American Epilepsy Society's 67th Annual Meeting in Washington, DC, by Marianna Spanaki-Varelas, M.D., the study's co-author and division head of the Henry Ford Comprehensive Epilepsy Program.

Each of the patients in the study group underwent resective surgery, in which the affected portion of their brain is removed, to treat refractory partial epilepsy. Refractory epilepsy, which affects about a third of those with the seizure disorder, is a form that resists treatment with medications.

The condition can severely damage patients' quality of life, leaving them wary of their next unpredictable seizure, limiting their ability to work full-time or successfully attend school and sometimes causing seizure-related injuries.

In such cases, resective surgery is considered an effective treatment. The most common procedure temporal resection involves removing the affected portion of the temporal lobe.

In other instances, seizure surgery is extra-temporal, in which a portion of the brain outside the temporal lobes including the frontal, parietal or occipital lobes is removed.

Henry Ford researchers used its databases to identify patients who had epilepsy surgery from 1993 to 2011. Of those 420 patients, 253 were surveyed by telephone to determine their current seizure frequency, driving status, employment status and use of antidepressants.

Of the 253 patients surveyed:

  • 82 patients (32 percent) were seizure free, and 189 (75 percent) had a favorable outcome.
  • Temporal resection was performed on 215 patients (85 percent) of the study group, with significant favorable outcomes.
  • Patients were more likely to be driving compared to before their surgery (51 percent versus 35 percent).
  • The difference in current full-time employment status was significantly higher in temporal resections compared to extra-temporal (45 percent versus 26 percent).
  • Patients with favorable surgical outcomes were more likely to be driving (65 percent versus 11 percent), employed (28 percent versus 8 percent), and less likely to be taking anti-depressants (24 percent versus 47 percent), compared to those without favorable outcomes.


'/>"/>

Contact: Dwight Angell
dwight.angell@hfhs.org
313-850-3471
Henry Ford Health System
Source:Eurekalert

Related medicine news :

1. ADHD study: Expensive training programs dont help kids grades, behavior
2. Study: Ureteral injury during robot-assisted prostate surgery
3. Study: Odds of rehospitalization of cognitively impaired varies by discharge destination
4. Mayo Clinic-led study: 2 drugs do not improve kidney function in acute heart failure patients
5. Regenstrief and IU study: Older adults with severe mental illness challenge healthcare system
6. Princeton study: Military children and their families remain an invisible subculture
7. Study: Access to health care increases prescription opioid availability and associated abuse
8. Study: Higher rates of diabetes, hypertension, heart disease and stroke found in food desert
9. U-M study: Smarter blood pressure guidelines could prevent many more heart attacks and strokes
10. IU study: Leadership void, not lack of money, slows efforts to address cervical cancer
11. New study: Enterocystoplasty in children with genitourinary abnormalities is safe and effective
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2017)... ... June 23, 2017 , ... ... fight against hunger on June 21, 2017, at the Emeryville Center of Community ... and malnutrition around the world. , Rise Against Hunger (formerly Stop Hunger Now) ...
(Date:6/20/2017)... MA (PRWEB) , ... June 20, 2017 , ... ... and CHRISTUS Health, a Texas-based health system, will present how predictive analytics drive ... annual HFMA ANI meeting in Orlando, June 25-28. , “The traditional approach ...
(Date:6/20/2017)... ... 2017 , ... After months of negotiations, FaceCradle USA is proud to announce the debut of ... , “Introducing our product on QVC is something we all worked hard to achieve for ... more than 90 million homes in the United States,” said FaceCradle USA President Dylan Doherty. ...
(Date:6/20/2017)... ... June 20, 2017 , ... Hayes, Inc., a leading provider ... titled “ 5 Questions to Ask Before Entering the Maze of Genetic Testing ... Evaluation (GTE) team, the book explores the various types of the more than ...
(Date:6/20/2017)... ... June 20, 2017 , ... Kenneth Mayer, MD, has been appointed ... , Dr. Mayer, who joined the JIAS Editorial Board in 2016, has co-authored more ... Director of Fenway Health and Co-Chair of The Fenway Institute, a member ...
Breaking Medicine News(10 mins):
(Date:6/8/2017)... , June 8, 2017  Less than a ... hit more than 200,000 companies, including hospital networks, in ... heralded as one of the largest online extortion attempts ... the healthcare market, it is imperative that providers understand ... their data from this — and many other very ...
(Date:6/7/2017)... 7, 2017  Novavax, Inc., (Nasdaq: NVAX ) ... 2 trials of its RSV F protein recombinant nanoparticle vaccine ... have been published in the journal Vaccine ... in prior scientific conferences). The Company previously announced top ... is developing the RSV F Vaccine with the goal of ...
(Date:6/3/2017)... June 3, 2017  Eli Lilly and Company ... results from the Phase 3 MONARCH 2 study ... 6 inhibitor, in combination with fulvestrant, significantly improved ... alone in women with hormone-receptor-positive (HR+), human epidermal ... who have relapsed or progressed after endocrine therapy ...
Breaking Medicine Technology: